Advertisement

Topics

Destiny Pharma Seeks AIM Listing To Advance First-In-Class Antibiotics

09:27 EDT 21 Aug 2017 | SCRIP

UK-based Destiny Pharma hopes its planned IPO will attract investor demand, backed by its promise of new anti-microbial drugs and...

      

Related Stories

 

Original Article: Destiny Pharma Seeks AIM Listing To Advance First-In-Class Antibiotics

NEXT ARTICLE

More From BioPortfolio on "Destiny Pharma Seeks AIM Listing To Advance First-In-Class Antibiotics"

Advertisement
Quick Search
Advertisement
Advertisement